Targeting the short form of cFLIP by RNA interference is sufficient to enhance TRAIL sensitivity in PC3 prostate carcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17106251

Download in:

View as

General Info

PMID
17106251